Nevertheless, together our results provide new insights into the mechanisms underlying MOID and also sugget that future development of TSG101 as well as MAD2 inhibitors can be an effective therapy for killing MAD2-overexpressing tumor cells. This evidence concerns the gene MAD2L1 and neoplasm.